Share Name Share Symbol Market Type Share ISIN Share Description
Allergan Plc LSE:0Y7T London Ordinary Share IE00BY9D5467 ALLERGAN ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 154.21 0.00 0.00 0.00 0.00 0.00 163 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
- - - - 0

Bank of America Merrill Lynch Form 38.5 (b) - Allergan

22/01/2020 11:20am

UK Regulatory (RNS & others)


Allergan (LSE:0Y7T)
Historical Stock Chart

2 Months : From Dec 2019 to Feb 2020

Click Here for more Allergan Charts.

TIDM0Y7T

RNS Number : 6016A

Bank of America Merrill Lynch

22 January 2020

FORM 38.5(b)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT

RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY

STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 
1.  KEY INFORMATION 
 
 
 Name of exempt principal trader             Bank of America, N.A., Proprietary 
 Company dealt in                            Allergan PLC 
                                            ----------------------------------- 
 Class of relevant security to which the     Common - IE00BY9D5467 
   dealings being disclosed relate(Note 1) 
                                            ----------------------------------- 
 Date of dealing                             21/01/2020 
                                            ----------------------------------- 
 
 
2.  INTERESTS AND SHORT POSITIONS 
 
 
(a)  Interests and short positions (following dealing) 
      in the class of relevant security 
      dealt in (Note 2) 
 
 
 Class of relevant security: Common               IE00BY9D5467 
                                                  Long                 Short 
                                                 -------------------  ------------------- 
                                                  Number      %        Number      % 
                                                 ----------  -------  ----------  ------- 
 (1)  Relevant securities                         3,532,969   1.076%   0           0 % 
                                                 ----------  -------  ----------  ------- 
 (2)  Derivatives (other than options):           1,786,127   0.544%   5,012,097   1.526% 
                                                 ----------  -------  ----------  ------- 
 (3)  Options and agreements to purchase/sell:    0           0%       0           0% 
                                                 ----------  -------  ----------  ------- 
      Total                                       5,319,096   1.62%    5,012,097   1.526% 
                                                 ----------  -------  ----------  ------- 
 
 
(b)  Interests and short positions in relevant securities 
      of the company, other than the 
      class dealt in (Note 2) 
 
 
 Class of relevant security: 
                                                  Long          Short 
                                                 ------------  ------------ 
                                                  Number   %    Number   % 
                                                 -------  ---  -------  --- 
 (1)  Relevant securities                         0        0%   0        0% 
                                                 -------  ---  -------  --- 
 (2)  Derivatives (other than options):           0        0%   0        0% 
                                                 -------  ---  -------  --- 
 (3)  Options and agreements to purchase/sell:    0        0%   0        0% 
                                                 -------  ---  -------  --- 
      Total                                       0        0%   0        0% 
                                                 -------  ---  -------  --- 
 
 
3.  DEALINGS (Note 3) 
 
 
(a)  Purchases and sales 
 
 
 Purchase/sale   Number of relevant securities   Price per unit (Note 4) 
 Purchase            1,161                       192.58 USD 
                ------------------------------  ------------------------ 
 Purchase               698                      192.633 USD 
                ------------------------------  ------------------------ 
 Purchase               806                      192.68 USD 
                ------------------------------  ------------------------ 
 
 
 Purchase/sale   Number of relevant securities   Price per unit (Note 4) 
 Sale            806                             192.68 USD 
                ------------------------------  ------------------------ 
 
 
(b)  Derivatives transactions (other than options transactions) 
 
 
 Product name,   Nature of transaction         Number of relevant securities   Price per unit 
  e.g. CFD        (Note 5)                      (Note 6)                        (Note 4) 
     Swaps        Reducing a Long Position                  388                  192.68 USD 
                ----------------------------  ------------------------------  --------------- 
     Swaps        Reducing a Long Position                  59                   192.68 USD 
                ----------------------------  ------------------------------  --------------- 
     Swaps        Reducing a Long Position                  50                   192.68 USD 
                ----------------------------  ------------------------------  --------------- 
     Swaps        Reducing a Long Position                  124                  192.68 USD 
                ----------------------------  ------------------------------  --------------- 
     Swaps       Increasing a Short Position                659                 192.636 USD 
                ----------------------------  ------------------------------  --------------- 
     Swaps       Increasing a Short Position                39                  192.636 USD 
                ----------------------------  ------------------------------  --------------- 
 
 
(c)  Options transactions in respect of existing relevant 
      securities 
 
 
(i)  Writing, selling, purchasing or varying 
 
 
  Product       Writing,       Number of      Exercise        Type,        Expiry date    Option money paid/ received 
    name,       selling,       securities       price     e.g. American,                       per unit (Note 4) 
  e.g. call    purchasing,      to which                     European 
   option        varying       the option                      etc 
                  etc.        relates (Note 
                                   7) 
    N/A           N/A             N/A           N/A            N/A             N/A                    N/A 
             -------------  ---------------  ---------  ----------------  ------------  ------------------------------ 
 
 
(ii)  Exercising 
 
 
  Product name,        Number of securities    Exercise price per 
   e.g. call option                             unit (Note 4) 
        N/A                    N/A                    N/A 
                     ----------------------  -------------------- 
 
 
(d)  Other dealings (including transactions in respect 
      of new securities) (Note 3) 
 
 
  Nature or transaction    Details    Price per unit 
   (Note 7)                            (if applicable) (Note 4) 
          N/A               N/A                 N/A 
                         ---------  --------------------------- 
 
 
4.  OTHER INFORMATION 
 

Agreements, arrangements or understandings relating to options or derivatives

 
 Full details of any agreement, arrangement or understanding between the person 
  disclosing and any other person relating to the voting rights of any relevant 
  securities under any option referred to on this form or relating to the voting rights 
  or future acquisition or disposal of any relevant securities to which any derivative 
  referred to on this form is referenced. If none, this should be stated. 
 None 
 
 
Is a Supplemental Form 38.5(b) attached? (Note 8)  No 
 
 
 Date of disclosure                              22/01/2020 
 Contact name                                    Tolu Tade 
                                                ------------------------ 
 Telephone number                                +44207 996 3410 
                                                ------------------------ 
 Name of offeree/offeror with which connected    AbbVie Inc 
                                                ------------------------ 
 Nature of connection (Note 9)                   Advisor to - AbbVie Inc 
                                                ------------------------ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ISESEUFFEESSEFF

(END) Dow Jones Newswires

January 22, 2020 06:20 ET (11:20 GMT)

1 Year Allergan Chart

1 Year Allergan Chart

1 Month Allergan Chart

1 Month Allergan Chart
Your Recent History
LSE
0Y7T
Allergan
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200223 11:44:36